The recent travel ban announced by President Trump extends indefinite restrictions on citizens from twelve countries, triggering concern among the scientific community. This policy, effective June 9, includes countries previously targeted by the 2017 travel bans and adds new ones such as Afghanistan and Myanmar. Experts, including evolutionary biologist Kristian Andersen, warn that these restrictions will severely impact infectious disease research and collaboration. While the immediate effect may be small on student populations, heightened immigration restrictions foreshadow serious consequences for American research universities, potentially leading to drastic institutional measures in response to ongoing challenges.
Kristian Andersen, an evolutionary biologist at Scripps Research, states that the travel restrictions will disrupt infectious-disease research and response, especially for countries facing epidemics.
A researcher from a major American university described the travel ban as a 'straw that breaks the camel's back,' highlighting the survival of American research institutions.
David Levine, a health economist, emphasizes the extensive disruption to various ongoing research projects due to the sudden travel restrictions imposed by the administration.
Collection
[
|
...
]